![Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)]()
Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Saraceni, Francesco; Labopin, Myriam; Brecht, Arne; Kröger, Nicolaus; Eder, Matthias; Tischer, Johanna; Labussière-Wallet, Hélène; Einsele, Hermann; Beelen, Dietrich; Bunjes, Donald; Niederwieser, Dietger; Bochtler, Tilmann; Savani, Bipin N.; Mohty, Mohamad; Nagler, Arnon · Journal of Hematology & Oncology · 2019